Skip to main content

WellPoint Invests In Medical Tourism

From the AIS Report on Blue Cross and Blue Shield Plans: 
"WellPoint's pilot program, called the Global Health Care Partnership, will allow employees of Serigraph to access benefits for certain common elective procedures at designated facilities in India starting in January 2009. Serigraph, a Wisconsin-based printing company, has 650 U.S. employees. The procedures include major joint replacement and upper and lower spinal fusion. "The U.S. retail price for knee replacement surgery is approximately $70,000, while the same procedure costs approximately $8,500 in India," says Razia Hashmi, M.D., chief medical officer for WellPoint's national accounts." (emphasis mine.)
Providers ignore this trend at their own peril and, in my experience, most are paying scant attention.  Insurers like WellPoint are focusing these programs around the few high-margin services providers have left.  They're content to leave onshore all the unprofitable diagnoses - the sepsis and pneumonia, the ER and obstetrics - until there are better, cheaper options for them too.  And it doesn't take too many high-end procedures - ortho, neuro, cardiac, transplants - moving overseas before hospitals' already-dwindling profit margins disappear entirely.

My advice: stop worrying so much about the competitor down the street or across town.  You've spent years battling back and forth...and after all that, how much market share have you really gained or lost?  If you're livin' large on high-end surgery, the real threat may be in Bangalore.

Along the way you'll undoubtedly hear comments like "Oh, OUR patients LOVE us.  They'd NEVER fly half-way around the world to a strange country for major surgery..."   I hope you're right.  (And for your organization's sake, you'd BETTER be right.)  But exactly how many high-margin cases can you lose before you're below water?  Here's 61,500 reasons ($70,000 - $8,500) to find out.

I have some thoughts on how to approach the analysis; contact me and we'll discuss.

More on medical tourism from Deloitte, including a forecasted increase in patients traveling overseas for care from 750,000 in 2007 to 6 million in 2010.


Comments

Popular posts from this blog

Michael Porter On Health Care Reform

Michael Porter, writing in the New England Journal of Medicine, proposes "A Strategy For Health Care Reform - Toward A Value-Based System." His proposals are fundamental, lucid and right-on, meaning they're sure to be opposed by some parties to the debate, the so-called "Yes, but..." crowd. Most important, in my opinion, is this: "... electronic medical records will enable value improvement, but only if they support integrated care and outcome measurement. Simply automating current delivery practices will be a hugely expensive exercise in futility. Among our highest near-term priorities is to finalize and then continuously update health information technology (HIT) standards that include precise data definitions (for diagnoses and treatments, for example), an architecture for aggregating data for each patient over time and across providers, and protocols for seamless communication among systems. "Finally, consumers must become much mor

Being Disrupted Ain't Fun. Deal With It.

Articles about disrupting healthcare, particularly those analogizing, say, Tesla's example with healthcare's current state, are frequently met with a chorus of (paraphrasing here) "Irrelevant! Cars are easy, healthcare is hard." You know, patients and doctors as examples of "information asymmetry" and all that. Well, let me ask you this: assuming you drive a car with a traditional internal combustion engine, how much do you know about the metallurgy in your car's engine block? I'll bet the answer is: virtually nothing. In fact it's probably less than you know about your own body's GI tract. Yet somehow, every day, us (allegedly) ignorant people buy and drive cars without help from a cadre of experts. Most of us do so and live happily ever after (at least until the warranty expires. Warranties...another thing healthcare could learn from Tesla.) Now, us free range dummies - impatient with information asymmetry - are storming healthcare

My Take On Anthem-Cigna, Big Dumb Companies and the Executives Who Run Them

After last Friday's Appeals Court decision, Anthem's hostile takeover of, er, merger with Cigna has but a faint pulse. Good. Unplug the respirator. Cigna's figured it out but Anthem is like that late-late horror show where the corpse refuses to die. Meanwhile, 150 McKinsey consultants are on standby for post-merger "integration" support. I guess "no deal, no paycheck..." is powerfully motivating to keep the patient alive a while longer. In court, Anthem argued that assembling a $54 billion behemoth is a necessary precondition to sparking all manner of wondrous innovations and delivering $2.4 billion in efficiencies. The basic argument appears to be "We need to double in size to grow a brain. And just imagine all those savings translating directly into lower premiums for employers and consumers."  Stop. Read that paragraph again. Ignore the dubious "lower premiums" argument and focus on the deal's savings. $2.4 billion saved